Skip to content
Riskpilot
← Back to search
Sign in
Get full access
NORD VACC LÄKEMEDEL AKTIEBOLAG
AB
Active
Org 5563231090
Västertorpsvägen 135 B, 129 44
Hägersten
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 1988
3 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
NORD VACC LÄKEMEDEL AKTIEBOLAG
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
3M
6M
9M
13M
4M
2020
5M
2021
6M
2022
7M
2023
11M
2024
EBITDA
SEK millions
0M
-0M
-1M
-1M
-1M
-4M
2020
-3M
2021
-1M
2022
-10M
2023
-3M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
3 801
4 645
6 451
7 359
10 921
Staff expenses
—
—
—
—
—
EBITDA
−3 518
−2 869
−1 028
−10 098
−3 286
Depreciation & amort.
−206
−155
−91
−11
−11
EBIT
−3 724
−3 024
−1 119
−10 109
−3 297
Net financials
47
−35
369
−231
−87
Profit before tax
0
0
0
1 348
151
Tax
−0
−0
−0
−1 593
−0
Net profit
0
0
0
−245
151
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
4 729
4 888
8 563
5 100
6 233
Equity
565
565
565
320
471
Long-term debt
1 072
1 047
6 560
2 939
3 631
Short-term debt
3 092
3 276
1 438
1 841
2 131
Total debt
4 164
4 323
7 998
4 780
5 762
Financial ratios
5-year trend
EBITDA margin
-30.1%
This company
15.8%
Market median
-291% vs market
2020
2024
Equity ratio
7.6%
This company
38.2%
Market median
-80% vs market
2020
2024
Return on equity
32.1%
This company
18.4%
Market median
+74% vs market
2020
2024
Net profit margin
1.4%
This company
8.1%
Market median
-83% vs market
2020
2024
Asset turnover
1.75×
This company
1.12×
Market median
+56% vs market
2020
2024
Debt / equity
12.23×
This company
0.62×
Market median
-1873% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on NORD VACC LÄKEMEDEL AKTIEBOLAG
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
